Peter Smith

Company: United Therapeutics Corp.

Job title: Vice President Product Development


Analyzing Design of a Phase 3 Trial for Inhaled Treprostinil 5:00 pm

• Exploring the scientific rationale behind inhaled Treprostinil • Phase 3 trial design and special considerations of inhaled candidate for evaluating the long-term safety and tolerability of TreprostinilRead more

day: Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.